Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways.
Yang D, Chan JF, Yoon C, Luk TY, Shuai H, Hou Y, Huang X, Hu B, Chai Y, Yuen TT, Liu Y, Zhu T, Liu H, Shi J, Wang Y, He Y, Sit KY, Au WK, Zhang AJ, Yuan S, Zhang BZ, Huang YW, Chu H.
Yang D, et al. Among authors: zhang bz.
J Med Virol. 2024 Feb;96(2):e29472. doi: 10.1002/jmv.29472.
J Med Virol. 2024.
PMID: 38373201